TELA Bio (TELA) Return on Capital Employed Growth (3y) (2022 - 2026)
TELA Bio (TELA) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | - |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn | 2,415.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,415.00 |
| Dec 31, 2025 | 57.00 |
| Sep 30, 2025 | -42.00 |
| Jun 30, 2025 | 1,450.00 |
| Mar 31, 2025 | 781.00 |
| Dec 31, 2024 | -950.00 |
| Sep 30, 2024 | -4,960.00 |
| Jun 30, 2024 | -3,514.00 |
| Mar 31, 2024 | -2,906.00 |
| Dec 31, 2023 | -3,654.00 |
| Sep 30, 2023 | -2,743.00 |
| Jun 30, 2023 | -3,518.00 |
| Mar 31, 2023 | -4,800.00 |
| Dec 31, 2022 | -1,421.00 |
| Sep 30, 2022 | 22,890.00 |